Acquisition Opportunity Recent acquisition by Ephicacy Consulting Group suggests a shift in strategic alignment and potential cross-sell of biostatistical and data management services to a broader client base within a larger platform. Sales teams should target integration opportunities, joint offerings, and expanded scope with the combined entity.

Growth Potential Annual revenue range indicates a mid-size firm with room for expansion in clinical trial support services, data management, and biostatistics. Approach with scalable solutions that adapt to growing trial complexity and international projects to capture additional work from existing and new clients.

Boutique Capacity Employee count under 50 signals agility and specialized expertise. Position ARAs strengths in customized, flexible partnerships to win mid-to-large biotech and medtech engagements that require rapid deployment, tight collaboration, and bespoke analytics.

Strategic Fit Core competencies in transparency, strategic partnership, and flexible resourcing align with customers seeking outsourced data management and biostatistics as an extension of their team. Emphasize integration capability, rapid issue resolution, and scalable staffing in pitches.

Tech Enablement Current tech stack and digital presence present opportunities to offer data governance, analytics enablement, and integrated reporting capabilities. Propose modernized data workflows, secure data exchange, and analytics dashboards to attract tech-forward pharmaceutical clients.